SAB Biotherapeutics Inc.(SABS:US)

Market Cap$211.24M

Key Metrics

Price$2.53

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$12.78M

EBITDA (TTM)-$66.18M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$8.27M

Total Assets$238.21M

Net Assets$214.79M

Total Debt$5.13M

SAB Biotherapeutics Inc.(SABS:US)

Market Cap$211.24M

Price history

Key Metrics

Price$2.53

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$12.78M

EBITDA (TTM)-$66.18M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$8.27M

Total Assets$238.21M

Net Assets$214.79M

Total Debt$5.13M

Financials

NameJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021
Revenue
$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$11.8M$0$0$0$0
Cost of Revenue
----------------------
Gross Profit
----------------------
$23.38M$20M$15.77M$12.68M$9.73M$10.77M$10.01M$11.31M$10.2M$11.39M$18.87M$5.32M$6.48M$7.4M$7.86M$7.81M$6.54M$6.71M-$3.99M$2.87M-$813.92K
Research and Development$16.17M$13.4M$10.73M$8.97M$7M$7.66M$7.65M$7.83M$6.82M$8.15M$4.3M$4.02M$3.66M$4.54M$7.14M$7.35M$8.58M$13.32M-$15.07M$18.68M$12.78M
Selling, General, and Administrative$7.21M$6.6M$5.04M$3.71M$2.74M$3.11M$2.47M$3.48M$3.64M$4.19M$14.88M$2.57M$2.9M$3.45M$2.88M$4.04M$4.31M$5.19M-$3.6M$2.4M$3.33M
Other Operating Expenses-------$114.7K--$263.14K-$944.58K-$305.01K-$1.27M-$85.52K-$581.1K-$2.16M-$3.59M-$6.35M-$11.8M--$14.68M-$18.21M-$16.93M
Operating Income
-$23.38M-$20M-$15.77M-$12.68M-$9.73M-$10.77M-$10.01M-$11.31M-$10.2M-$11.39M-$18.87M-$5.32M-$6.48M-$7.4M-$7.86M-$7.81M-$6.54M$5.1M-$12.69M-$3.99M-$2.87M$813.92K
$886K$1.13M-$1.09M$58.12M-$382.21K$5.58M-$1.39M$959.96K$2.87M$6.36M-$3.98M$220.61K-$404.27K$48.19K$11.04K$731.25K$1.67M$7.79M-$4.6M-$70.84K-$66.17K$595.91K
Non-Operating Interest Income$1.71M$1.05M$700.74K$655.23K$13.56K$62.5K$136.37K$277.17K$374.56K$497.89K$484.05K$14.36K$28.57K$57.99K$29.93K$17.39K$15.82K$7.93K$14.87K$3.77K$5.3K$5.51K
Non-Operating Interest Expense$62K$62.75K$63.46K$43.29K$64.35K$69.57K$70.88K$78.04K$93.12K$76.37K$77.88K$69.7K$75.32K$92.39K$87.7K$70.63K$71.24K$72.02K-$78.56K$74.43K$75.19K
Other Income/Expense-$761K$144.4K-$1.73M$57.51M-$331.43K$5.58M-$1.45M$760.82K$2.58M$5.94M-$4.39M$275.94K-$357.52K$82.59K$68.81K$784.49K$1.73M$7.85M-$4.62M$3.95K$2.97K$665.6K
Income Before Tax
-$22.49M-$18.87M-$16.86M$45.45M-$10.11M-$5.2M-$11.39M-$10.35M-$7.34M-$5.03M-$22.86M-$5.1M-$6.88M-$7.35M-$7.85M-$7.08M-$4.87M$1.08M-$17.58M-$4.06M-$2.94M$1.41M
Income Tax
------------$0$0$25.63K$0-$92.28K$92.28K-$0$0$0
Net Income
-$22.49M-$18.87M-$16.86M$45.45M-$10.11M-$5.2M-$11.39M-$10.35M-$7.34M-$5.03M-$22.86M-$5.1M-$6.88M-$7.35M-$7.87M-$7.08M-$4.78M$985.86K-$17.58M-$4.06M-$2.94M$1.41M
Minority Interests
----------------------
Preferred Stock Dividends
----------------------
Net Income to Common
-$22.49M-$18.87M-$16.86M$45.45M-$10.11M-$5.2M-$11.39M-$10.35M-$7.34M-$5.03M-$22.86M-$5.1M-$6.88M-$7.35M-$7.87M-$7.08M-$4.78M$985.86K-$17.58M-$4.06M-$2.94M$1.41M
Shares Outstanding (Basic)
79.75M53.56M-10.66M9.29M9.29M-9.26M9.26M9.24M-5.24M5.04M5.04M-4.3M4.3M4.31M-4.35M4.35M4.35M
Shares Outstanding (Diluted)
79.75M53.56M-77.86M9.29M9.29M-9.26M9.26M9.24M-5.24M5.04M5.04M-4.3M4.3M4.58M-4.35M4.35M4.35M
EPS (Basic)
-$0.28-$0.35-$0.50-$1.09-$0.56--$1.12-$0.79-$0.54--$0.97-$1.36-$1.46--$1.60-$1.10$0.20--$0.93-$0.68$0.32
EPS (Diluted)
-$0.28-$0.35--$0.21-$1.09-$0.56--$1.12-$0.79-$0.54--$0.97-$1.36-$1.46--$1.60-$1.10$0.20--$0.93-$0.68$0.32
EBIT
-$22.43M-$18.81M-$16.8M$45.49M-$10.05M-$5.13M-$11.32M-$10.27M-$7.24M-$4.95M-$22.78M-$5.03M-$6.81M-$7.26M-$7.76M-$7.01M-$4.8M$1.15M-$16.15M-$3.98M-$2.87M$1.49M
EBITDA
-$20.48M-$17.57M-$12.78M-$15.34M-$8.65M-$9.38M-$8.23M-$9.31M-$8.4M-$8.43M-$17.11M-$4.23M-$5.56M-$6.42M-$6.87M-$6.88M-$5.75M-$6.02M-$11.52M-$3.57M-$2.57M$1.1M